FBIO

Fortress Biotech, Inc.

4.32

USD

FBIO Earnings Reports

Positive Surprise Ratio

FBIO beat 23 of 39 last estimates.

59%

Next Report

Date of Next Report

Mar 24, 2026

Estimate for Q4 25 (Revenue/ EPS)

$23.61M

-$0.35

Implied change from Q3 25 (Revenue/ EPS)

+33.90%

-418.18%

Implied change from Q4 24 (Revenue/ EPS)

+56.14%

-53.33%

Fortress Biotech, Inc. earnings per share and revenue

On Nov 14, 2025, FBIO reported earnings of 0.11 USD per share (EPS) for Q3 25, beating the estimate of -0.42 USD, resulting in a 125.68% surprise. Revenue reached 17.63 million, compared to an expected 21.44 million, with a -17.76% difference. The market reacted with a +5.22% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.35 USD, with revenue projected to reach 23.61 million USD, implying an decrease of -418.18% EPS, and increase of 33.90% in Revenue from the last quarter.

FAQ

What were Fortress Biotech, Inc.'s earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Fortress Biotech, Inc. reported EPS of $0.11, beating estimates by 125.68%, and revenue of $17.63M, -17.76% below expectations.

How did the market react to Fortress Biotech, Inc.'s Q3 2025 earnings?

The stock price moved up 5.22%, changed from $2.49 before the earnings release to $2.62 the day after.

When is Fortress Biotech, Inc. expected to report next?

The next earning report is scheduled for Mar 24, 2026.

What are the forecasts for Fortress Biotech, Inc.'s next earnings report?

Based on 4 analysts, Fortress Biotech, Inc. is expected to report EPS of -$0.35 and revenue of $23.61M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.